Holen Sie sich die Stockscreener-App
9.56
5.87%
0.53
Vorhandelsmarkt:
9.62
0.06
+0.63%
Schlusskurs vom Vortag:
$9.03
Offen:
$9.2
24-Stunden-Volumen:
9,748
Relative Volume:
0.65
Marktkapitalisierung:
$81.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.45M
KGV:
-0.4404
EPS:
-21.71
Netto-Cashflow:
$-31.81M
1W Leistung:
-13.09%
1M Leistung:
+15.32%
6M Leistung:
-8.17%
1J Leistung:
+34.65%
1-Tages-Spanne:
$9.11
$9.95
1-Wochen-Bereich:
$9.03
$10.95
52-Wochen-Spanne:
$5.90
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Firmenname
Surrozen Inc
Sektor
Branche
Telefon
650-475-2820
Adresse
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Vergleichen Sie SRZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
9.56 | 88.70M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-09-15 | Eingeleitet | Guggenheim | Buy |
| 2021-09-07 | Eingeleitet | Stifel | Buy |
Surrozen Inc Aktie (SRZN) Neueste Nachrichten
Key metrics from Surrozen Inc.’s quarterly dataAI Trend Detection for Entry Timing - Newser
Can Surrozen Inc. Equity Warrant hit a new high this monthTrading Volume Spike and Reversal Analysis - Newser
Developing predictive dashboards with Surrozen Inc. dataFree Risk Controlled Short Term Trade Plans - Newser
How to build a custom watchlist for Surrozen Inc.Free AI Forecast for Trending Stocks - Newser
How to forecast Surrozen Inc. trends using time seriesDaily Equity Signal Strength Summary Report - Newser
Is Surrozen Inc. building a consolidation basePredicted Market Direction Based on Momentum - Newser
How to manage a losing position in Surrozen Inc. Equity WarrantDaily Investment Ideas with Market Insight - Newser
Using R and stats models for Surrozen Inc. Equity Warrant forecastingFree Daily Volume Spike Trading Signals - Newser
Can trapped investors hope for a rebound in Surrozen Inc. Equity WarrantLow Risk Trade Timing with Analysis Metrics - Newser
Surrozen Inc. Equity Warrant stock trend forecastFree Secure Capital Picks With Upside Potential - Newser
Surrozen Inc. Equity Warrant stock chart pattern explained7-Day Equity Return Range Forecast Model - Newser
What makes Surrozen Inc. Equity Warrant stock price move sharplyBuy Strategy Tracker with Growth Indicators - Newser
Why Surrozen Inc. Equity Warrant stock attracts strong analyst attentionAI-Based Signal Detection for Active Traders - Newser
Surrozen's Q2 2025 Earnings: A Biotech Turnaround Driven by Strategic Gains and Ophthalmology Pipeline Progress - AInvest
Technical analysis overview for Surrozen Inc. stockFree Real Time Alerts Based on AI Prediction - Newser
Surrozen Inc.’s volatility index tracking explainedBuy Signal Forecast With Short-Term Data - Newser
What indicators show strength in Surrozen Inc. Equity WarrantTechnical Screener for High Growth Stocks - Newser
Published on: 2025-08-09 11:37:11 - beatles.ru
Detecting price anomalies in Surrozen Inc. with AILong Term Stock Planner with Safety Checks - Newser
Surrozen’s Q2 2025: Progress in Eye Disease Therapies - MSN
Is Surrozen Inc. Equity Warrant stock ready for a breakoutReal-Time Equity Price Action Analysis - Newser
What MACD and RSI say about Surrozen Inc. Equity WarrantFree Oversold Recovery Opportunity Stocks - Newser
Surrozen Inc. Equity Warrant recovery potential after sell offLong Term Stock Planner with Safety Checks - Newser
Surrozen Reports Q2 Profit on Gains - AOL.com
European Equity Fund, Inc. shares rise 1.52% after-hours following recent financial results from Canopy Growth and Surrozen. - AInvest
Surrozen Reports Q2 Profit on Gains - The Motley Fool
Surrozen Flips To Profit And Draws Bullish Analyst Buzz - Finimize
Surrozen posts Q2 net income of $39.7 mln - MarketScreener
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update - Morningstar
Why Surrozen Inc. stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
Analyzing net buyer seller activity in Surrozen Inc. Equity WarrantShort-Term Market Movement Forecast Report - Newser
Historical volatility pattern of Surrozen Inc. Equity Warrant visualizedShort-Term Profit Alert With Entry Forecast - Newser
Can you recover from losses in Surrozen Inc. Equity WarrantReversal Signal Prediction Based on Volume - Newser
Is it time to cut losses on Surrozen Inc.Market Timing Strategy with Technical Filters - Newser
Multi asset correlation models including Surrozen Inc.Long-Term Signal Tracking and Profit Summary - Newser
Surrozen to Present at Upcoming Healthcare Investor Conference - The Manila Times
Surrozen Showcases Breakthrough Eye Disease Therapeutics at Major Healthcare Conference - Stock Titan
Is Surrozen Inc. a Top Dividend Stock to Watch in 2025Summary of Consistent Growth Stock Picks - Newser
Finanzdaten der Surrozen Inc-Aktie (SRZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):